Frequently Asked Questions
The market is segmented based on Global Nucleic Acid-Based Therapeutics Market, By Application Monogenic Disorders and Multigenic Disorders, Structure (Single Stranded RNA/DNA, Double Stranded DNA), Technologies (Anti-Sense Technology, Gene Therapy, RNA and DNA Therapy, Aptamers, Nucleoside Analogs, and Others), End-Users (Hospitals, Research Institutes, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) – Industry Trends and Forecast to 2030.
.
The Global Nucleic Acid Based Therapeutics Market size was valued at USD 3783.72 USD million in 2022.
The Global Nucleic Acid Based Therapeutics Market is projected to grow at a CAGR of 14.29% during the forecast period of 2023 to 2030.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
